» Articles » PMID: 2897806

Intranasal Sufentanil for Pre-operative Sedation

Overview
Journal Anaesthesia
Specialty Anesthesiology
Date 1988 Apr 1
PMID 2897806
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Sufentanil, a short-acting and potent narcotic agent, was studied as a premedicant administered by the nasal route. A total dose of 5 micrograms appeared to be too low, while either 10 or 20 micrograms was very effective in producing sedation. Side effects were minor. There appeared to be no differences between nose drops and spray. In a further study, sufentanil nose drops were compared with saline 0.9% in a double-blind fashion. Sedation of rapid onset but of limited duration was observed in the majority of patients who received sufentanil.

Citing Articles

Combination of propofol and nasal sufentanil or intravenous midazolam for colonoscopy: a comparative study.

Akarsu Ayazoglu T, Uzman S Anaesthesiol Intensive Ther. 2021; 53(2):146-152.

PMID: 34284552 PMC: 10158433. DOI: 10.5114/ait.2021.106298.


[Intranasal fentanyl for breakthrough cancer pain. A pilot study.].

Striebel H, Wessel A, Rieger A Schmerz. 1993; 7(3):174-7.

PMID: 18415403 DOI: 10.1007/BF02530425.


[New modes of opioid administration.].

Striebel H, Schwagmeier R, Boerger N Schmerz. 1993; 7(3):131-9.

PMID: 18415398 DOI: 10.1007/BF02530420.


Recent advances in the pharmacological management of pain.

Guindon J, Walczak J, Beaulieu P Drugs. 2007; 67(15):2121-33.

PMID: 17927280 DOI: 10.2165/00003495-200767150-00002.


Anesthesia for the 21st century.

Stanley T Proc (Bayl Univ Med Cent). 2006; 13(1):7-10.

PMID: 16389318 PMC: 1312206. DOI: 10.1080/08998280.2000.11927635.